Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Imgn-853
2. Imgn853
1. Humov 19
2. Unii-98de7vn88d
3. Imgn853
4. Imgn 853
5. Mirvetuximab Soravtansine [usan]
6. Mirvetuximab-soravtansine
7. 98de7vn88d
8. Imgn-853
9. Schembl16447449
10. 1453084-37-1
11. Immunoglobulin G1, Anti-(human Folate Receptor Alpha) (human-mus Musculus Monoclonal M9346a Heavy Chain), Disulfide With Human-mus Musculus Monoclonal M9346a Light Chain, Dimer, Tetraamide With N2'-(4-((3-carboxy-3-sulfopropyl)dithio)-4-methyl-1-oxopentyl)-n2'-deacetylmaytansine
12. Q27272114
Molecular Weight | 977.6 g/mol |
---|---|
Molecular Formula | C42H61ClN4O14S3 |
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 16 |
Exact Mass | 976.3034938 g/mol |
Monoisotopic Mass | 976.3034938 g/mol |
Topological Polar Surface Area | 313 Ų |
Heavy Atom Count | 64 |
Formal Charge | 0 |
Complexity | 1890 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of fallopian tube cancer , Treatment of ovarian carcinoma, Treatment of peritoneal carcinoma
Regulatory Info :
Registration Country : USA
MIRVETUXIMAB SORAVTANSINE-GYNX
Brand Name : ELAHERE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 100mg/20mL single-dose vial
Packaging :
Approval Date :
Application Number : 761310
Regulatory Info :
Registration Country : USA
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?